Prostate cancer diagnosis journal. Lista exportálása irodalomjegyzékként
The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Prostate ; — Molecular pathology of prostate cancer.
Early Diagnosis of Prostate Cancer: A Path Forward
Molecular subtypes and perspectives of targeted therapies in prostate cancer. Molecular underpinnings prostate cancer diagnosis journal systemic treatment resistance in metastatic castration-resistant prostate cancer. Dvostruki navodi Integrative clinical genomics of advanced prostate cancer.
- Hogyan lehet segíteni egy embert prosztatitisben
- MTMT2: citation list
Cell ; — Germline and somatic mutations in prostate cancer for the clinician. J Natl Compr Canc Netw.
New aspect of photodynamic diagnosis of bladder tumors: The fluorescence cytology. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer. Fluorescence cytology with 5-aminolevulinic acid in EUS-guided FNA as a method for differentiating between malignant and benign lesions.
Germline genetic testing in prostate cancer — further enrichment in variant histologies? Oncoscience ; 5: 62— Inherited DNA-repair gene mutations in men with metastatic prostate cancer.
N Engl J Med. Eur Urol. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Kalina Ildikó dr. Summary The MRI scanners operating in our country with 1.
J Clin Oncol. The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Varga Dániel dr. Summary Introduction: According to the scientific literature, formation of a psoas abscess following prostate biopsy is extremely rare. Furthermore, there has not been any report yet on a case of a two-sided abscess invading the paralumbal muscles requiring surgical intervention.
Prostate cancer diagnosis journal analysis of three metastatic prostate cancer patients with exceptional responses to carboplatin indicating different types of DNA repair deficiency. Prostate Cancer. Version 2. Mutations in BRCA2 and taxane resistance in prostate cancer.